MedTrace Logo

HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC

NCT04961970 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 188

Last updated 2021-07-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) of oxaliplatin, 5-fluorouracil and leucovorin compared systemic chemotherapy of gemcitabine and cisplatin in patients with unresectable intrahepatic cholangiocarcinoma.

Conditions

  • Intrahepatic Cholangiocarcinoma

Interventions

DRUG

oxaliplatin , fluorouracil, and leucovorin

administration of oxaliplatin , fluorouracil, and leucovorin via the tumor feeding arteries

DRUG

gemcitabine and cisplatin

administration of gemcitabine and cisplatin via vein

Sponsors & Collaborators

  • Shi Ming

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-09
Primary Completion
2025-07-09
Completion
2025-07-09

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04961970 on ClinicalTrials.gov